CN108277212B - 脂肪酶突变体Gly183Cys/Gly212Cys及其基因和应用 - Google Patents
脂肪酶突变体Gly183Cys/Gly212Cys及其基因和应用 Download PDFInfo
- Publication number
- CN108277212B CN108277212B CN201711475025.7A CN201711475025A CN108277212B CN 108277212 B CN108277212 B CN 108277212B CN 201711475025 A CN201711475025 A CN 201711475025A CN 108277212 B CN108277212 B CN 108277212B
- Authority
- CN
- China
- Prior art keywords
- lipase
- ttl
- gly
- ala
- leu
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108090001060 Lipase Proteins 0.000 title claims abstract description 81
- 102000004882 Lipase Human genes 0.000 title claims abstract description 70
- 239000004367 Lipase Substances 0.000 title claims abstract description 69
- 235000019421 lipase Nutrition 0.000 title claims abstract description 69
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 13
- 102200018555 rs121912926 Human genes 0.000 title description 3
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract 2
- 238000012545 processing Methods 0.000 claims description 6
- 230000003301 hydrolyzing effect Effects 0.000 claims description 3
- 235000013305 food Nutrition 0.000 claims description 2
- 239000002773 nucleotide Substances 0.000 claims description 2
- 125000003729 nucleotide group Chemical group 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 239000003599 detergent Substances 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 108090000790 Enzymes Proteins 0.000 abstract description 46
- 102000004190 Enzymes Human genes 0.000 abstract description 45
- 230000000694 effects Effects 0.000 abstract description 36
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 6
- 238000010353 genetic engineering Methods 0.000 abstract description 2
- 229940088598 enzyme Drugs 0.000 description 41
- 241000235058 Komagataella pastoris Species 0.000 description 9
- 230000009471 action Effects 0.000 description 8
- 239000013598 vector Substances 0.000 description 8
- 239000007788 liquid Substances 0.000 description 7
- 150000001413 amino acids Chemical class 0.000 description 6
- 238000000855 fermentation Methods 0.000 description 6
- 230000004151 fermentation Effects 0.000 description 6
- 238000010438 heat treatment Methods 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- 239000013604 expression vector Substances 0.000 description 5
- 108010069926 arginyl-glycyl-serine Proteins 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- 239000007853 buffer solution Substances 0.000 description 4
- 108010089804 glycyl-threonine Proteins 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 108010084455 Zeocin Proteins 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 235000019626 lipase activity Nutrition 0.000 description 3
- CWCMIVBLVUHDHK-ZSNHEYEWSA-N phleomycin D1 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC[C@@H](N=1)C=1SC=C(N=1)C(=O)NCCCCNC(N)=N)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C CWCMIVBLVUHDHK-ZSNHEYEWSA-N 0.000 description 3
- 239000013612 plasmid Substances 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 238000002741 site-directed mutagenesis Methods 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- NHCPCLJZRSIDHS-ZLUOBGJFSA-N Ala-Asp-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(O)=O NHCPCLJZRSIDHS-ZLUOBGJFSA-N 0.000 description 2
- AJBVYEYZVYPFCF-CIUDSAMLSA-N Ala-Lys-Asn Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O AJBVYEYZVYPFCF-CIUDSAMLSA-N 0.000 description 2
- IPZQNYYAYVRKKK-FXQIFTODSA-N Ala-Pro-Ala Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O IPZQNYYAYVRKKK-FXQIFTODSA-N 0.000 description 2
- KLKARCOHVHLAJP-UWJYBYFXSA-N Ala-Tyr-Cys Chemical compound C[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(O)=O KLKARCOHVHLAJP-UWJYBYFXSA-N 0.000 description 2
- UXJCMQFPDWCHKX-DCAQKATOSA-N Arg-Arg-Glu Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(O)=O)C(O)=O UXJCMQFPDWCHKX-DCAQKATOSA-N 0.000 description 2
- QAXCZGMLVICQKS-SRVKXCTJSA-N Arg-Glu-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCN=C(N)N)N QAXCZGMLVICQKS-SRVKXCTJSA-N 0.000 description 2
- WVNFNPGXYADPPO-BQBZGAKWSA-N Arg-Gly-Ser Chemical compound NC(N)=NCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O WVNFNPGXYADPPO-BQBZGAKWSA-N 0.000 description 2
- VYZBPPBKFCHCIS-WPRPVWTQSA-N Arg-Val-Gly Chemical compound OC(=O)CNC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CCCN=C(N)N VYZBPPBKFCHCIS-WPRPVWTQSA-N 0.000 description 2
- QEYJFBMTSMLPKZ-ZKWXMUAHSA-N Asn-Ala-Val Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(O)=O QEYJFBMTSMLPKZ-ZKWXMUAHSA-N 0.000 description 2
- ZWASIOHRQWRWAS-UGYAYLCHSA-N Asn-Asp-Ile Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O ZWASIOHRQWRWAS-UGYAYLCHSA-N 0.000 description 2
- FUHFYEKSGWOWGZ-XHNCKOQMSA-N Asn-Gln-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC(=O)N)N)C(=O)O FUHFYEKSGWOWGZ-XHNCKOQMSA-N 0.000 description 2
- UDSVWSUXKYXSTR-QWRGUYRKSA-N Asn-Gly-Tyr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O UDSVWSUXKYXSTR-QWRGUYRKSA-N 0.000 description 2
- PTSDPWIHOYMRGR-UGYAYLCHSA-N Asn-Ile-Asn Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(O)=O PTSDPWIHOYMRGR-UGYAYLCHSA-N 0.000 description 2
- UPAGTDJAORYMEC-VHWLVUOQSA-N Asn-Trp-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CC(=O)N)N UPAGTDJAORYMEC-VHWLVUOQSA-N 0.000 description 2
- TVVYVAUGRHNTGT-UGYAYLCHSA-N Asp-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC(O)=O TVVYVAUGRHNTGT-UGYAYLCHSA-N 0.000 description 2
- OEUQMKNNOWJREN-AVGNSLFASA-N Asp-Gln-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC(=O)O)N OEUQMKNNOWJREN-AVGNSLFASA-N 0.000 description 2
- JUWZKMBALYLZCK-WHFBIAKZSA-N Asp-Gly-Asn Chemical compound OC(=O)C[C@H](N)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O JUWZKMBALYLZCK-WHFBIAKZSA-N 0.000 description 2
- KHGPWGKPYHPOIK-QWRGUYRKSA-N Asp-Gly-Phe Chemical compound [H]N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O KHGPWGKPYHPOIK-QWRGUYRKSA-N 0.000 description 2
- TZOZNVLBTAFJRW-UGYAYLCHSA-N Asp-Ile-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CC(=O)O)N TZOZNVLBTAFJRW-UGYAYLCHSA-N 0.000 description 2
- HKEZZWQWXWGASX-KKUMJFAQSA-N Asp-Leu-Phe Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 HKEZZWQWXWGASX-KKUMJFAQSA-N 0.000 description 2
- YIDFBWRHIYOYAA-LKXGYXEUSA-N Asp-Ser-Thr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O YIDFBWRHIYOYAA-LKXGYXEUSA-N 0.000 description 2
- 241000218631 Coniferophyta Species 0.000 description 2
- NXTYATMDWQYLGJ-BQBZGAKWSA-N Cys-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CS NXTYATMDWQYLGJ-BQBZGAKWSA-N 0.000 description 2
- NXQCSPVUPLUTJH-WHFBIAKZSA-N Cys-Ser-Gly Chemical compound SC[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O NXQCSPVUPLUTJH-WHFBIAKZSA-N 0.000 description 2
- 241000763274 Eupodium Species 0.000 description 2
- ININBLZFFVOQIO-JHEQGTHGSA-N Gln-Thr-Gly Chemical compound C[C@H]([C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CCC(=O)N)N)O ININBLZFFVOQIO-JHEQGTHGSA-N 0.000 description 2
- UBRQJXFDVZNYJP-AVGNSLFASA-N Gln-Tyr-Ser Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CCC(=O)N)N)O UBRQJXFDVZNYJP-AVGNSLFASA-N 0.000 description 2
- ZFBBMCKQSNJZSN-AUTRQRHGSA-N Gln-Val-Gln Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O ZFBBMCKQSNJZSN-AUTRQRHGSA-N 0.000 description 2
- JRCUFCXYZLPSDZ-ACZMJKKPSA-N Glu-Asp-Ser Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O JRCUFCXYZLPSDZ-ACZMJKKPSA-N 0.000 description 2
- CUXJIASLBRJOFV-LAEOZQHASA-N Glu-Gly-Ile Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(O)=O CUXJIASLBRJOFV-LAEOZQHASA-N 0.000 description 2
- ATVYZJGOZLVXDK-IUCAKERBSA-N Glu-Leu-Gly Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O ATVYZJGOZLVXDK-IUCAKERBSA-N 0.000 description 2
- BRFJMRSRMOMIMU-WHFBIAKZSA-N Gly-Ala-Asn Chemical compound NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(O)=O BRFJMRSRMOMIMU-WHFBIAKZSA-N 0.000 description 2
- QXPRJQPCFXMCIY-NKWVEPMBSA-N Gly-Ala-Pro Chemical compound C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)CN QXPRJQPCFXMCIY-NKWVEPMBSA-N 0.000 description 2
- LJPIRKICOISLKN-WHFBIAKZSA-N Gly-Ala-Ser Chemical compound NCC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O LJPIRKICOISLKN-WHFBIAKZSA-N 0.000 description 2
- YOBGUCWZPXJHTN-BQBZGAKWSA-N Gly-Ser-Arg Chemical compound NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCN=C(N)N YOBGUCWZPXJHTN-BQBZGAKWSA-N 0.000 description 2
- ZZWUYQXMIFTIIY-WEDXCCLWSA-N Gly-Thr-Leu Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O ZZWUYQXMIFTIIY-WEDXCCLWSA-N 0.000 description 2
- VGYOLSOFODKLSP-IHPCNDPISA-N His-Leu-Trp Chemical compound C([C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)C1=CN=CN1 VGYOLSOFODKLSP-IHPCNDPISA-N 0.000 description 2
- NKVZTQVGUNLLQW-JBDRJPRFSA-N Ile-Ala-Ala Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O)N NKVZTQVGUNLLQW-JBDRJPRFSA-N 0.000 description 2
- WEWCEPOYKANMGZ-MMWGEVLESA-N Ile-Cys-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)O)N WEWCEPOYKANMGZ-MMWGEVLESA-N 0.000 description 2
- UYODHPPSCXBNCS-XUXIUFHCSA-N Ile-Val-Leu Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC(C)C UYODHPPSCXBNCS-XUXIUFHCSA-N 0.000 description 2
- 241000880493 Leptailurus serval Species 0.000 description 2
- DLCOFDAHNMMQPP-SRVKXCTJSA-N Leu-Asp-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O DLCOFDAHNMMQPP-SRVKXCTJSA-N 0.000 description 2
- QJXHMYMRGDOHRU-NHCYSSNCSA-N Leu-Ile-Gly Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(O)=O QJXHMYMRGDOHRU-NHCYSSNCSA-N 0.000 description 2
- ZDBMWELMUCLUPL-QEJZJMRPSA-N Leu-Phe-Ala Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C)C(O)=O)CC1=CC=CC=C1 ZDBMWELMUCLUPL-QEJZJMRPSA-N 0.000 description 2
- LCNASHSOFMRYFO-WDCWCFNPSA-N Leu-Thr-Gln Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CCC(N)=O LCNASHSOFMRYFO-WDCWCFNPSA-N 0.000 description 2
- 108010062166 Lys-Asn-Asp Proteins 0.000 description 2
- BYPMOIFBQPEWOH-CIUDSAMLSA-N Lys-Asn-Asp Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)N BYPMOIFBQPEWOH-CIUDSAMLSA-N 0.000 description 2
- UETQMSASAVBGJY-QWRGUYRKSA-N Lys-Gly-His Chemical compound NCCCC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC1=CNC=N1 UETQMSASAVBGJY-QWRGUYRKSA-N 0.000 description 2
- DTUZCYRNEJDKSR-NHCYSSNCSA-N Lys-Gly-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN DTUZCYRNEJDKSR-NHCYSSNCSA-N 0.000 description 2
- SITLTJHOQZFJGG-UHFFFAOYSA-N N-L-alpha-glutamyl-L-valine Natural products CC(C)C(C(O)=O)NC(=O)C(N)CCC(O)=O SITLTJHOQZFJGG-UHFFFAOYSA-N 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- VCYJKOLZYPYGJV-AVGNSLFASA-N Pro-Arg-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(O)=O VCYJKOLZYPYGJV-AVGNSLFASA-N 0.000 description 2
- DEDANIDYQAPTFI-IHRRRGAJSA-N Pro-Asp-Tyr Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O DEDANIDYQAPTFI-IHRRRGAJSA-N 0.000 description 2
- JLMZKEQFMVORMA-SRVKXCTJSA-N Pro-Pro-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 JLMZKEQFMVORMA-SRVKXCTJSA-N 0.000 description 2
- YDTUEBLEAVANFH-RCWTZXSCSA-N Pro-Val-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]1CCCN1 YDTUEBLEAVANFH-RCWTZXSCSA-N 0.000 description 2
- ZIFYDQAFEMIZII-GUBZILKMSA-N Ser-Leu-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O ZIFYDQAFEMIZII-GUBZILKMSA-N 0.000 description 2
- JAWGSPUJAXYXJA-IHRRRGAJSA-N Ser-Phe-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CO)N)CC1=CC=CC=C1 JAWGSPUJAXYXJA-IHRRRGAJSA-N 0.000 description 2
- CKDXFSPMIDSMGV-GUBZILKMSA-N Ser-Pro-Val Chemical compound [H]N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(O)=O CKDXFSPMIDSMGV-GUBZILKMSA-N 0.000 description 2
- CUXJENOFJXOSOZ-BIIVOSGPSA-N Ser-Ser-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CO)NC(=O)[C@H](CO)N)C(=O)O CUXJENOFJXOSOZ-BIIVOSGPSA-N 0.000 description 2
- SXAGUVRFGJSFKC-ZEILLAHLSA-N Thr-His-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O SXAGUVRFGJSFKC-ZEILLAHLSA-N 0.000 description 2
- KZSYAEWQMJEGRZ-RHYQMDGZSA-N Thr-Leu-Val Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O KZSYAEWQMJEGRZ-RHYQMDGZSA-N 0.000 description 2
- WNQJTLATMXYSEL-OEAJRASXSA-N Thr-Phe-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(O)=O WNQJTLATMXYSEL-OEAJRASXSA-N 0.000 description 2
- NDXSOKGYKCGYKT-VEVYYDQMSA-N Thr-Pro-Asp Chemical compound C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(O)=O NDXSOKGYKCGYKT-VEVYYDQMSA-N 0.000 description 2
- SGAOHNPSEPVAFP-ZDLURKLDSA-N Thr-Ser-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)NCC(O)=O SGAOHNPSEPVAFP-ZDLURKLDSA-N 0.000 description 2
- WPSKTVVMQCXPRO-BWBBJGPYSA-N Thr-Ser-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O WPSKTVVMQCXPRO-BWBBJGPYSA-N 0.000 description 2
- TWJDQTTXXZDJKV-BPUTZDHNSA-N Trp-Arg-Ser Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(O)=O TWJDQTTXXZDJKV-BPUTZDHNSA-N 0.000 description 2
- KDGFPPHLXCEQRN-STECZYCISA-N Tyr-Arg-Ile Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O KDGFPPHLXCEQRN-STECZYCISA-N 0.000 description 2
- OKDNSNWJEXAMSU-IRXDYDNUSA-N Tyr-Phe-Gly Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)NCC(O)=O)C1=CC=C(O)C=C1 OKDNSNWJEXAMSU-IRXDYDNUSA-N 0.000 description 2
- BCOBSVIZMQXKFY-KKUMJFAQSA-N Tyr-Ser-His Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N)O BCOBSVIZMQXKFY-KKUMJFAQSA-N 0.000 description 2
- HRHYJNLMIJWGLF-BZSNNMDCSA-N Tyr-Ser-Phe Chemical compound C([C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=C(O)C=C1 HRHYJNLMIJWGLF-BZSNNMDCSA-N 0.000 description 2
- KUXCBJFJURINGF-PXDAIIFMSA-N Tyr-Trp-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CC3=CC=C(C=C3)O)N KUXCBJFJURINGF-PXDAIIFMSA-N 0.000 description 2
- UEOOXDLMQZBPFR-ZKWXMUAHSA-N Val-Ala-Asn Chemical compound C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](C(C)C)N UEOOXDLMQZBPFR-ZKWXMUAHSA-N 0.000 description 2
- ZXAGTABZUOMUDO-GVXVVHGQSA-N Val-Glu-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)N ZXAGTABZUOMUDO-GVXVVHGQSA-N 0.000 description 2
- VPGCVZRRBYOGCD-AVGNSLFASA-N Val-Lys-Val Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O VPGCVZRRBYOGCD-AVGNSLFASA-N 0.000 description 2
- KISFXYYRKKNLOP-IHRRRGAJSA-N Val-Phe-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)O)N KISFXYYRKKNLOP-IHRRRGAJSA-N 0.000 description 2
- RYHUIHUOYRNNIE-NRPADANISA-N Val-Ser-Gln Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N RYHUIHUOYRNNIE-NRPADANISA-N 0.000 description 2
- BZDGLJPROOOUOZ-XGEHTFHBSA-N Val-Thr-Cys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](C(C)C)N)O BZDGLJPROOOUOZ-XGEHTFHBSA-N 0.000 description 2
- 108010044940 alanylglutamine Proteins 0.000 description 2
- 108010047495 alanylglycine Proteins 0.000 description 2
- 108010070944 alanylhistidine Proteins 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 108010013835 arginine glutamate Proteins 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- XBGGUPMXALFZOT-UHFFFAOYSA-N glycyl-L-tyrosine hemihydrate Natural products NCC(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 XBGGUPMXALFZOT-UHFFFAOYSA-N 0.000 description 2
- 108010050848 glycylleucine Proteins 0.000 description 2
- 108010085325 histidylproline Proteins 0.000 description 2
- 108010027338 isoleucylcysteine Proteins 0.000 description 2
- 108010034529 leucyl-lysine Proteins 0.000 description 2
- 108010073472 leucyl-prolyl-proline Proteins 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- 108010012581 phenylalanylglutamate Proteins 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 108010004914 prolylarginine Proteins 0.000 description 2
- 108010070643 prolylglutamic acid Proteins 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000003259 recombinant expression Methods 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 108010044292 tryptophyltyrosine Proteins 0.000 description 2
- IBIDRSSEHFLGSD-UHFFFAOYSA-N valinyl-arginine Natural products CC(C)C(N)C(=O)NC(C(O)=O)CCCN=C(N)N IBIDRSSEHFLGSD-UHFFFAOYSA-N 0.000 description 2
- 108010011667 Ala-Phe-Ala Proteins 0.000 description 1
- DHONNEYAZPNGSG-UBHSHLNASA-N Ala-Val-Phe Chemical compound C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 DHONNEYAZPNGSG-UBHSHLNASA-N 0.000 description 1
- VDCIPFYVCICPEC-FXQIFTODSA-N Asn-Arg-Ala Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(O)=O VDCIPFYVCICPEC-FXQIFTODSA-N 0.000 description 1
- YJRORCOAFUZVKA-FXQIFTODSA-N Asn-Arg-Cys Chemical compound C(C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CC(=O)N)N)CN=C(N)N YJRORCOAFUZVKA-FXQIFTODSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 102100031375 Endothelial lipase Human genes 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- CNNQBZRGQATKNY-DCAQKATOSA-N Leu-Arg-Cys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CS)C(=O)O)N CNNQBZRGQATKNY-DCAQKATOSA-N 0.000 description 1
- KSZCCRIGNVSHFH-UWVGGRQHSA-N Leu-Arg-Gly Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O KSZCCRIGNVSHFH-UWVGGRQHSA-N 0.000 description 1
- ZJZNLRVCZWUONM-JXUBOQSCSA-N Leu-Thr-Ala Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O ZJZNLRVCZWUONM-JXUBOQSCSA-N 0.000 description 1
- XZFYRXDAULDNFX-UHFFFAOYSA-N N-L-cysteinyl-L-phenylalanine Natural products SCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 XZFYRXDAULDNFX-UHFFFAOYSA-N 0.000 description 1
- XMBSYZWANAQXEV-UHFFFAOYSA-N N-alpha-L-glutamyl-L-phenylalanine Natural products OC(=O)CCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 XMBSYZWANAQXEV-UHFFFAOYSA-N 0.000 description 1
- CYZBFPYMSJGBRL-DRZSPHRISA-N Phe-Ala-Glu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O CYZBFPYMSJGBRL-DRZSPHRISA-N 0.000 description 1
- CMHTUJQZQXFNTQ-OEAJRASXSA-N Phe-Leu-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)N)O CMHTUJQZQXFNTQ-OEAJRASXSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 229940079919 digestives enzyme preparation Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 108010019832 glycyl-asparaginyl-glycine Proteins 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 239000006225 natural substrate Substances 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 102220315568 rs1039799564 Human genes 0.000 description 1
- 102200108107 rs587780728 Human genes 0.000 description 1
- 102220158290 rs886062405 Human genes 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 238000005809 transesterification reaction Methods 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/18—Carboxylic ester hydrolases (3.1.1)
- C12N9/20—Triglyceride splitting, e.g. by means of lipase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/01—Carboxylic ester hydrolases (3.1.1)
- C12Y301/01003—Triacylglycerol lipase (3.1.1.3)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
本发明涉及基因工程领域,具体涉及一种热稳定性提高的脂肪酶TTL突变体TTL‑Gly183Cys/Gly212Cys及其基因和应用。所述脂肪酶TTL突变体TTL‑Gly183Cys/Gly212Cys的氨基酸序列如SEQ ID NO.4所示。突变体在80℃水浴5min后剩余酶活为46.2%,提高至亲本脂肪酶的2.52倍。
Description
技术领域
本发明涉及基因工程领域,具体涉及一种热稳定性提高的脂肪酶TTL突变体TTL-Gly183Cys/Gly212Cys及其基因和应用。
背景技术
脂肪酶(EC 3.1.1.3)全称三酰基甘油酰水解酶,属于α/β折叠酶家族,是一种丝氨酸水解酶。脂肪酶不仅可以在油水界面上催化天然底物油脂水解,释放更少酯键的甘油酯或甘油及脂肪酸,而且在非水相体系中脂肪酶还可催化酸解、转酯和酯合成等反应。工业饲料用脂肪酶主要来源于微生物,微生物分泌的脂肪酶具有较广的作用pH值和作用温度。随着酶催化技术的不断推广,酶制剂的应用条件也越来越严格,如高温、强酸强碱等特殊条件。脂肪酶作为一种重要的酶种被广泛地应用到食品加工、饲料、洗涤、医药等领域。油脂加工和饲料制粒等工艺通常需在较高温度下进行,热稳定性差的脂肪酶在上述工艺中易失活变性,因此开发高热稳定性脂肪酶一直是学术和产业界努力的目标。
为了得到更优的酶制剂,一方面可以从自然界筛选合适的酶基因,另一个途经就是将现有产业化的酶蛋白通过分子生物学技术进行改造,以适应不同产业的需求。现今改造酶蛋白的策略主要有两个,其一是非理性设计,通过随机突变改造酶的基因,再根据特定的改造目的,筛选出更符合其作用条件的酶蛋白。此策略优点是无须深入研究酶的结构和作用机理,但需要极大的工作量去完成筛选,效率偏低。
有文献报道科学家从突尼斯南部火山地区分离得到一株嗜热裸足菌,其分泌脂肪酶具有较好的耐热性,70℃处理1h后剩余50%酶活。毕赤酵母培养条件简单、易于工业化生产且高效分泌表达外源蛋白,已成功表达多个外源源脂肪酶。本发明利用毕赤酵母高效分泌表达嗜热裸足菌来源的脂肪酶,并以嗜热裸足菌脂肪酶基于为模板,通过定点突变技术获得热稳定性显著提高的脂肪酶突变体。
发明内容
本发明的目的在于提供高热稳定性的脂肪酶TTL。所述高热稳定性脂肪酶TTL,是由亲本脂肪酶TTL进行定点突变,获得的脂肪酶突变体。用于表达所述脂肪酶的突变体的表达载体为pPICZαA和pPIC9K;用于所述表达载体转化的宿主细胞是毕赤酵母X33和GS115。所述脂肪酶突变体为:TTL-Gly183Cys/Gly212Cys。
野生型的脂肪酶基因全长825个碱基(SEQ ID No.1)及其编码的274个氨基酸(SEQID No.2)
SEQ ID NO.1
TCTCCAGTCAGACGTGAGGTTTCTCAGGACTTGTTCGACCAGTTTAATTTGTTCGCTCAGTACTCTGCTGCTGCCTACTGTGCCAAGAATAACGATGCCCCAGCTGGTGCTAACGTTACCTGTAGAGGTTCCATCTGCCCAGAGGTTGAGAAGGCTGACGCCACCTTCTTGTACTCTTTCGAGGACTCTGGAGTTGGTGACGTTACCGGTTTCTTGGCTTTGGACAACACCAACAGATTGATCGTCTTGTCTTTCCGTGGTTCCCGTTCCCTTGAGAATTGGATCGGTAACATTAATTTGGATTTGAAGGGTATCGACGACATCTGCTCTGGTTGCAAGGGACACGATGGTTTCACCTCCTCTTGGAGATCCGTTGCCAACACCTTGACCCAACAGGTTCAGAACGCCGTTAGAGAGCATCCAGACTACCGTGTCGTCTTCACTGGTCACTCTTTGGGTGGTGCTTTGGCTACCGTTGCTGGTGCCTCTTTGAGAGGTAACGGTTACGACATCGACGTTTTCTCCTACGGTGCTCCTCGTGTTGGTAACAGAGCCTTCGCTGTCTTCTTGACCGCTCAGACCGGTGGTACCTTGTACAGAATCACCCATACCAACGATATCGTCCCACGTTTGCCACCAAGAGAGCTTGGATACTCCCACTCTTCCCCAGAGTACTGGATCACCTCCGGTACTTTGGTTCCAGTTACCAAGAACGATATTGTTAAGGTTGAGGGAATTGACTCCACCGACGGTAACAACCAGCCAAATACCCCAGACATTGCTGCCCACTTGTGGTACTTCGGTTTGATTGGTACTTGTTTGTAA
SEQ ID NO.2
SPVRREVSQDLFDQFNLFAQYSAAAYCAKNNDAPAGANVTCRGSICPEVEKADATFLYSFEDSGVGDVTGFLALDNTNRLIVLSFRGSRSLENWIGNINLDLKGIDDICSGCKGHDGFTSSWRSVANTLTQQVQNAVREHPDYRVVFTGHSLGGALATVAGASLRGNGYDIDVFSYGAPRVGNRAFAEFLTAQTGGTLYRITHTNDIVPRLPPRELGYSHSSPEYWITSGTLVPVTKNDIVKVEGIDSTDGNNQPNTPDIAAHLWYFGLIGTCL
突变后脂肪酶基因全长825个碱基(如核苷酸序列SEQ ID NO.3所示),其编码的274个氨基酸(如氨基酸序列SEQ ID NO.4所示)。
SEQ ID NO.3
TCTCCAGTCAGACGTGAGGTTTCTCAGGACTTGTTCGACCAGTTTAATTTGTTCGCTCAGTACTCTGCTGCTGCCTACTGTGCCAAGAATAACGATGCCCCAGCTGGTGCTAACGTTACCTGTAGAGGTTCCATCTGCCCAGAGGTTGAGAAGGCTGACGCCACCTTCTTGTACTCTTTCGAGGACTCTGGAGTTGGTGACGTTACCGGTTTCTTGGCTTTGGACAACACCAACAGATTGATCGTCTTGTCTTTCCGTGGTTCCCGTTCCCTTGAGAATTGGATCGGTAACATTAATTTGGATTTGAAGGGTATCGACGACATCTGCTCTGGTTGCAAGGGACACGATGGTTTCACCTCCTCTTGGAGATCCGTTGCCAACACCTTGACCCAACAGGTTCAGAACGCCGTTAGAGAGCATCCAGACTACCGTGTCGTCTTCACTGGTCACTCTTTGGGTGGTGCTTTGGCTACCGTTGCTGGTGCCTCTTTGAGATGTAACGGTTACGACATCGACGTTTTCTCCTACGGTGCTCCTCGTGTTGGTAACAGATGTTTCGCTGTCTTCTTGACCGCTCAGACCGGTGGTACCTTGTACAGAATCACCCATACCAACGATATCGTCCCACGTTTGCCACCAAGAGAGCTTGGATACTCCCACTCTTCCCCAGAGTACTGGATCACCTCCGGTACTTTGGTTCCAGTTACCAAGAACGATATTGTTAAGGTTGAGGGTATTGACTCTACCGACGGTAACAACCAGCCAAATACCCCAGACATTGCTGCCCACTTGTGGTACTTCGGTTTGATTGGTACTTGTTTGTAA
SEQ ID NO.4
SPVRREVSQDLFDQFNLFAQYSAAAYCAKNNDAPAGANVTCRGSICPEVEKADATFLYSFEDSGVGDVTGFLALDNTNRLIVLSFRGSRSLENWIGNINLDLKGIDDICSGCKGHDGFTSSWRSVANTLTQQVQNAVREHPDYRVVFTGHSLGGALATVAGASLRCNGYDIDVFSYGAPRVGNRCFAVFLTAQTGGTLYRITHTNDIVPRLPPRELGYSHSSPEYWITSGTLVPVTKNDIVKVEGIDSTDGNNQPNTPDIAAHLWYFGLIGTCL
亲本脂肪酶TTL在80℃水浴5min后剩余酶活为18.3%。本发明利用分子生物学技术定点突变脂肪酶TTL,获得了热稳定性提高的脂肪酶突变体TTL-Ala36Ser/Asp49His/Ala52Val/Asn55Asp。突变体TTL-Gly183Cys/Gly212Cys在80℃水浴5min后剩余酶活为46.2%,提高至亲本脂肪酶的2.52倍。
附图说明
图1含pPICzαA-TTL的毕赤酵母X33重组菌50L罐发酵图。
图2发酵各时间段酶液的蛋白电泳图。
图3脂肪酶TTL的酶学性质图。
图4脂肪酶突变体的酶学性质图
具体实施方式
为了增加脂肪酶的工业应用价值,本发明将脂肪酶基因TTL在毕赤酵母中进行表达,进一步研究此脂肪酶三维结构后,针对其关键特性的氨基酸突变以增进其热稳定性。以下将详述本发明改造脂肪酶的方法及其所得到的改良的脂肪酶。
以下实施例中未作具体说明的分子生物学实验方法,均参照《分子克隆实验指南》(第三版)J.萨姆布鲁克一书中所列的具体方法进行,或者按照试剂盒和产品说明书进行;所述试剂和生物材料,如无特殊说明,均可从商业途径获得。
实验材料和试剂:
1、菌株与载体
大肠杆菌菌株Topl0、毕赤酵母X33,GS115、载体pPICzαA,Ppic9K,Zeocin购自Invitrogen公司。
2、酶与试剂盒
PCR酶,限制性内切酶,质粒提取和凝胶纯化试剂盒购自上海生工公司。
实施例1、脂肪酶TTL在毕赤酵母X33中的高效表达
1.将脂肪酶基因TTL作为目标基因,野生型的脂肪酶基因全长825个碱基(SEQ IDNo.1)及其编码的274个氨基酸(SEQ ID No.2),利用限制性切酶EcoRI和XbaI酶切后,构建到pPICzαA载体中得到表达载体pPICzαA-TTL,再将pPICzαA-TTL转化Top 10感受态细胞,经抗生素Zeocin筛选后,得到阳性克隆。将上述重组表达载体用SacI进行线性化,线性化后的重组载体电击转化毕赤酵母X33,得到毕赤酵母重组菌株转化子。将上述重组菌单菌落进行高密度发酵培养。在发酵过程中的定时取样测定酶活,脂肪酶的表达情况如图1所示,发酵189h时脂肪酶酶活为31500U/mL。将上述发酵液中的脂肪酶通过硫酸铵分级沉淀、充分透析、再通过离子交换柱层析纯化,将纯化后的蛋白液进行12%SDS-PAGE检测,结果如图2。
2.脂肪酶活力测定采用橄榄油乳化液水解滴定法,酶活的定义为:脂肪酶在40℃、pH 7.0条件下水解橄榄油乳化液产生1μmol/min脂肪酸所消耗的酶量,即为1个脂肪酶活力单位。脂肪酶热处理采用水浴法,将酶液适当稀释后置于玻璃试管中,在不同温度水浴锅(70℃~90℃)中保温5min。
实施例2、脂肪酶TTL的酶学性质测定
1.脂肪酶TTL的最适反应温度和热稳定性测定
在30℃~80℃下,以10℃为间隔,分别测定脂肪酶的活力,以50℃下的酶活力为对照,测定不同温度下的相对酶活。结果如图3(a),脂肪酶作用的最适合温度为50℃。将脂肪酶酶液置于玻璃试管中,在不同温度下(70℃~90℃)热处理5min,测定残留脂肪酶活力,以未处理的酶活力为对照,热处理后的酶活与之相比,即得到该温度下剩余的相对酶活。结果如图3(b),80℃热处理5min后脂肪酶剩余酶活为18.3%。
2.脂肪酶TTL的最适反应pH和pH稳定性测定
在不同pH(3.0~9.0)的缓冲液体系中分别测定脂肪酶的酶活,以pH值7.0的酶活为对照,计算不同pH值下的相对酶活。结果如图3(c),脂肪酶作用的最适pH值为7.0。向上述不同pH的缓冲液体系中分别加入稀释好的酶液,室温处理2h,测定残留脂肪酶活力,以未处理的酶活力为对照,计算该pH下剩余的相对酶活。测定结果如图3(d)该酶的pH稳定范围较广,在pH5.0~9.0范围内酶活稳定。
实施例3、热稳定性提高的脂肪酶突变体TTL-Gly183Cys/Gly212Cys
1/以质粒pPICZαA-TTL为模板,分别以引物F1、PIC-R和引物R1、PIC-F进行PCR扩增,再将得到2个DNA片段进行融合PCR,得到重组载体pPICZαA-TTL-G183C。以质粒pPICZαA-TTL-G183C为模板,分别以引物F2、PIC-R和引物R2、PIC-F进行PCR扩增,再将得到2个DNA片段进行融合PCR,得到重组载体pPICZαA-TTL-G183CG212C。将上述重组载体转化Top 10感受态细胞,经抗生素Zeocin筛选后,得到阳性克隆。将上述重组表达载体用SacI进行线性化,线性化后的重组载体电击转化毕赤酵母X33,得到毕赤酵母重组菌株转化子。突变后脂肪酶基因全长825个碱基,由此推导出274个氨基酸。
所用引物如下:
F1:5’-CTCTTTGAGATGTAACGGTTACGACATCGACG-3’
R1:5’-CGTAACCGTTACATCTCAAAGAGGCACCAGC-3’
F2:5’-CTCAGACCTGTGGTACCTTGTACAGAATCACCC-3’
R2:5’-GTACAAGGTACCACAGGTCTGAGCGGTCAAGA-3’
PIC-F:5’-CTTGCTTGAGAAGGTTTTGGGACGC-3’
PIC-R:5’-CTTGGAGCGAACGACCTACACCGAA-3’
2、重组脂肪酶的最适反应温度和热稳定性测定
在30℃~80℃下,以10℃为间隔,分别测定脂肪酶的活力,以50℃下的酶活力为对照,测定不同温度下的相对酶活。结果如图4(a),脂肪酶作用的最适合温度为50℃。将脂肪酶酶液在不同温度(70℃~90℃)热处理5min,测定残留脂肪酶活力,以未处理的酶活力为对照,计算得到该温度下剩余的相对酶活。结果如图4(b),80℃热处理5min后脂肪酶剩余酶活为46.2%。
3、重组脂肪酶的最适反应pH和pH稳定性测定
在不同pH(3.0~9.0)的缓冲液体系中分别测定脂肪酶的酶活,以pH值7.0的酶活为对照,测定不同pH值下的相对酶活。结果如图4(c)所示:该脂肪酶作用的最适pH值为7.0。向上述不同pH的缓冲液体系中分别加入稀释好的酶液,室温处理2h,测定残留脂肪酶活力,以未处理的酶活力为对照,处理后酶液的酶活与之相比,即得到该pH下剩余的相对酶活。测定结果如图4(d),该酶的pH稳定范围较广,在pH 5.0~9.0范围内酶活稳定。
序列表
<110> 广东溢多利生物科技股份有限公司
<120> 脂肪酶突变体Gly183Cys/Gly212Cys及其基因和应用
<160> 4
<170> SIPOSequenceListing 1.0
<210> 1
<211> 825
<212> DNA
<213> 人工序列(Artificial Sequence)
<400> 1
tctccagtca gacgtgaggt ttctcaggac ttgttcgacc agtttaattt gttcgctcag 60
tactctgctg ctgcctactg tgccaagaat aacgatgccc cagctggtgc taacgttacc 120
tgtagaggtt ccatctgccc agaggttgag aaggctgacg ccaccttctt gtactctttc 180
gaggactctg gagttggtga cgttaccggt ttcttggctt tggacaacac caacagattg 240
atcgtcttgt ctttccgtgg ttcccgttcc cttgagaatt ggatcggtaa cattaatttg 300
gatttgaagg gtatcgacga catctgctct ggttgcaagg gacacgatgg tttcacctcc 360
tcttggagat ccgttgccaa caccttgacc caacaggttc agaacgccgt tagagagcat 420
ccagactacc gtgtcgtctt cactggtcac tctttgggtg gtgctttggc taccgttgct 480
ggtgcctctt tgagaggtaa cggttacgac atcgacgttt tctcctacgg tgctcctcgt 540
gttggtaaca gagccttcgc tgtcttcttg accgctcaga ccggtggtac cttgtacaga 600
atcacccata ccaacgatat cgtcccacgt ttgccaccaa gagagcttgg atactcccac 660
tcttccccag agtactggat cacctccggt actttggttc cagttaccaa gaacgatatt 720
gttaaggttg agggaattga ctccaccgac ggtaacaacc agccaaatac cccagacatt 780
gctgcccact tgtggtactt cggtttgatt ggtacttgtt tgtaa 825
<210> 2
<211> 274
<212> PRT
<213> 人工序列(Artificial Sequence)
<400> 2
Ser Pro Val Arg Arg Glu Val Ser Gln Asp Leu Phe Asp Gln Phe Asn
1 5 10 15
Leu Phe Ala Gln Tyr Ser Ala Ala Ala Tyr Cys Ala Lys Asn Asn Asp
20 25 30
Ala Pro Ala Gly Ala Asn Val Thr Cys Arg Gly Ser Ile Cys Pro Glu
35 40 45
Val Glu Lys Ala Asp Ala Thr Phe Leu Tyr Ser Phe Glu Asp Ser Gly
50 55 60
Val Gly Asp Val Thr Gly Phe Leu Ala Leu Asp Asn Thr Asn Arg Leu
65 70 75 80
Ile Val Leu Ser Phe Arg Gly Ser Arg Ser Leu Glu Asn Trp Ile Gly
85 90 95
Asn Ile Asn Leu Asp Leu Lys Gly Ile Asp Asp Ile Cys Ser Gly Cys
100 105 110
Lys Gly His Asp Gly Phe Thr Ser Ser Trp Arg Ser Val Ala Asn Thr
115 120 125
Leu Thr Gln Gln Val Gln Asn Ala Val Arg Glu His Pro Asp Tyr Arg
130 135 140
Val Val Phe Thr Gly His Ser Leu Gly Gly Ala Leu Ala Thr Val Ala
145 150 155 160
Gly Ala Ser Leu Arg Gly Asn Gly Tyr Asp Ile Asp Val Phe Ser Tyr
165 170 175
Gly Ala Pro Arg Val Gly Asn Arg Ala Phe Ala Glu Phe Leu Thr Ala
180 185 190
Gln Thr Gly Gly Thr Leu Tyr Arg Ile Thr His Thr Asn Asp Ile Val
195 200 205
Pro Arg Leu Pro Pro Arg Glu Leu Gly Tyr Ser His Ser Ser Pro Glu
210 215 220
Tyr Trp Ile Thr Ser Gly Thr Leu Val Pro Val Thr Lys Asn Asp Ile
225 230 235 240
Val Lys Val Glu Gly Ile Asp Ser Thr Asp Gly Asn Asn Gln Pro Asn
245 250 255
Thr Pro Asp Ile Ala Ala His Leu Trp Tyr Phe Gly Leu Ile Gly Thr
260 265 270
Cys Leu
<210> 3
<211> 825
<212> DNA
<213> 人工序列(Artificial Sequence)
<400> 3
tctccagtca gacgtgaggt ttctcaggac ttgttcgacc agtttaattt gttcgctcag 60
tactctgctg ctgcctactg tgccaagaat aacgatgccc cagctggtgc taacgttacc 120
tgtagaggtt ccatctgccc agaggttgag aaggctgacg ccaccttctt gtactctttc 180
gaggactctg gagttggtga cgttaccggt ttcttggctt tggacaacac caacagattg 240
atcgtcttgt ctttccgtgg ttcccgttcc cttgagaatt ggatcggtaa cattaatttg 300
gatttgaagg gtatcgacga catctgctct ggttgcaagg gacacgatgg tttcacctcc 360
tcttggagat ccgttgccaa caccttgacc caacaggttc agaacgccgt tagagagcat 420
ccagactacc gtgtcgtctt cactggtcac tctttgggtg gtgctttggc taccgttgct 480
ggtgcctctt tgagatgtaa cggttacgac atcgacgttt tctcctacgg tgctcctcgt 540
gttggtaaca gatgtttcgc tgtcttcttg accgctcaga ccggtggtac cttgtacaga 600
atcacccata ccaacgatat cgtcccacgt ttgccaccaa gagagcttgg atactcccac 660
tcttccccag agtactggat cacctccggt actttggttc cagttaccaa gaacgatatt 720
gttaaggttg agggtattga ctctaccgac ggtaacaacc agccaaatac cccagacatt 780
gctgcccact tgtggtactt cggtttgatt ggtacttgtt tgtaa 825
<210> 4
<211> 274
<212> PRT
<213> 人工序列(Artificial Sequence)
<400> 4
Ser Pro Val Arg Arg Glu Val Ser Gln Asp Leu Phe Asp Gln Phe Asn
1 5 10 15
Leu Phe Ala Gln Tyr Ser Ala Ala Ala Tyr Cys Ala Lys Asn Asn Asp
20 25 30
Ala Pro Ala Gly Ala Asn Val Thr Cys Arg Gly Ser Ile Cys Pro Glu
35 40 45
Val Glu Lys Ala Asp Ala Thr Phe Leu Tyr Ser Phe Glu Asp Ser Gly
50 55 60
Val Gly Asp Val Thr Gly Phe Leu Ala Leu Asp Asn Thr Asn Arg Leu
65 70 75 80
Ile Val Leu Ser Phe Arg Gly Ser Arg Ser Leu Glu Asn Trp Ile Gly
85 90 95
Asn Ile Asn Leu Asp Leu Lys Gly Ile Asp Asp Ile Cys Ser Gly Cys
100 105 110
Lys Gly His Asp Gly Phe Thr Ser Ser Trp Arg Ser Val Ala Asn Thr
115 120 125
Leu Thr Gln Gln Val Gln Asn Ala Val Arg Glu His Pro Asp Tyr Arg
130 135 140
Val Val Phe Thr Gly His Ser Leu Gly Gly Ala Leu Ala Thr Val Ala
145 150 155 160
Gly Ala Ser Leu Arg Cys Asn Gly Tyr Asp Ile Asp Val Phe Ser Tyr
165 170 175
Gly Ala Pro Arg Val Gly Asn Arg Cys Phe Ala Val Phe Leu Thr Ala
180 185 190
Gln Thr Gly Gly Thr Leu Tyr Arg Ile Thr His Thr Asn Asp Ile Val
195 200 205
Pro Arg Leu Pro Pro Arg Glu Leu Gly Tyr Ser His Ser Ser Pro Glu
210 215 220
Tyr Trp Ile Thr Ser Gly Thr Leu Val Pro Val Thr Lys Asn Asp Ile
225 230 235 240
Val Lys Val Glu Gly Ile Asp Ser Thr Asp Gly Asn Asn Gln Pro Asn
245 250 255
Thr Pro Asp Ile Ala Ala His Leu Trp Tyr Phe Gly Leu Ile Gly Thr
260 265 270
Cys Leu
Claims (5)
1.热稳定性提高的脂肪酶TTL突变体TTL-Gly183Cys/Gly212Cys,其特征在于,所述脂肪酶TTL突变体TTL-Gly183Cys/Gly212Cys的氨基酸序列如SEQ ID NO.4所示。
2.热稳定性提高的脂肪酶TTL突变体基因,其特征在于,编码权利要求1所述的热稳定性提高的脂肪酶TTL突变体TTL-Gly183Cys/Gly212Cys。
3.根据权利要求2所述的热稳定性提高的脂肪酶TTL突变体基因,其特征在于,其核苷酸序列如SEQ ID NO.3所示。
4.权利要求1所述的热稳定性提高的脂肪酶TTL突变体TTL-Gly183Cys/Gly212Cys用于在体外水解油脂的应用。
5.权利要求2所述的热稳定性提高的脂肪酶TTL突变体基因在食品加工、饲料加工、或洗涤剂制备中的应用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711475025.7A CN108277212B (zh) | 2017-12-29 | 2017-12-29 | 脂肪酶突变体Gly183Cys/Gly212Cys及其基因和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711475025.7A CN108277212B (zh) | 2017-12-29 | 2017-12-29 | 脂肪酶突变体Gly183Cys/Gly212Cys及其基因和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108277212A CN108277212A (zh) | 2018-07-13 |
CN108277212B true CN108277212B (zh) | 2019-12-10 |
Family
ID=62802650
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711475025.7A Active CN108277212B (zh) | 2017-12-29 | 2017-12-29 | 脂肪酶突变体Gly183Cys/Gly212Cys及其基因和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108277212B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111073876B (zh) * | 2020-01-18 | 2021-07-27 | 江南大学 | 热稳定性提高的枯草芽孢杆菌脂肪酶a |
AU2023272468A1 (en) | 2022-05-14 | 2024-11-14 | Novonesis Plant Biosolutions A/S | Compositions and methods for preventing, treating, supressing and/or eliminating phytopathogenic infestations and infections |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103459587A (zh) * | 2011-03-23 | 2013-12-18 | 布特马斯先进生物燃料有限责任公司 | 在发酵期间用于酶促生产醇酯的脂肪酶的原位表达 |
CN103865896A (zh) * | 2014-03-11 | 2014-06-18 | 上海康地恩生物科技有限公司 | 一种碱性脂肪酶突变体 |
-
2017
- 2017-12-29 CN CN201711475025.7A patent/CN108277212B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103459587A (zh) * | 2011-03-23 | 2013-12-18 | 布特马斯先进生物燃料有限责任公司 | 在发酵期间用于酶促生产醇酯的脂肪酶的原位表达 |
CN103865896A (zh) * | 2014-03-11 | 2014-06-18 | 上海康地恩生物科技有限公司 | 一种碱性脂肪酶突变体 |
Non-Patent Citations (2)
Title |
---|
GENBANK登录号:AEE61324.1;Lipase;《GENBANK》;20120208;参见序列 * |
GENBANK登录号:O59952.1;RecName:Full=Lipase;《GENBANK》;20150722;参见序列 * |
Also Published As
Publication number | Publication date |
---|---|
CN108277212A (zh) | 2018-07-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112574974B (zh) | 一种催化活性提高的脂肪酶突变体d163f及其应用 | |
CN109776686B (zh) | 一种热稳性提高的融合型脂肪酶及其制备方法和应用 | |
CN107488644B (zh) | 一种热稳定性提高的脂肪酶TTL突变体TTL-Gly60Glu/Ser61Asn及其基因和应用 | |
CN109750013B (zh) | 一种脂肪酶突变体及其制备方法和应用 | |
CN109971734B (zh) | 一种pH不敏感高温耐受性HSL家族脂类水解酶及应用 | |
CN107794251A (zh) | 一种深海新型耐碱酯酶及应用 | |
CN108277212B (zh) | 脂肪酶突变体Gly183Cys/Gly212Cys及其基因和应用 | |
CN111676210B (zh) | 一种提高纤维素酶活性的方法及纤维素酶突变体5i77-m和应用 | |
CN108315312B (zh) | 一种热稳定性提高的脂肪酶ttl突变体及其编码基因和应用 | |
CN108359655B (zh) | 一种热稳定性高的脂肪酶突变体TDL-mut及其编码基因 | |
CN107488648B (zh) | 热稳定性提高的脂肪酶TTL突变体TTL-Arg59Ser/Gly60Glu/Ser61Asn及基因和应用 | |
CN107488645B (zh) | 一种热稳定性提高的脂肪酶TTL突变体TTL-Ser61Asn及其基因和应用 | |
CN107488647B (zh) | 一种热稳定性提高的脂肪酶TTL突变体TTL-Gly60Glu及其基因和应用 | |
CN108913675B (zh) | 一种热稳定性提高的脂肪酶突变体及其应用 | |
CN107151660B (zh) | 脂肪酶变体Ala36Ser/Asp49His/Ala52Val/Asn55Asp | |
CN111139229B (zh) | 一种新型gdsl家族脂类水解酶eii-2及其编码基因与应用 | |
CN109750014B (zh) | 一种热稳性提高的融合型华根霉脂肪酶及其应用 | |
CN113684198A (zh) | 一种提高纤维素酶催化效率的方法及突变体5i77-m2 | |
CN107488646B (zh) | 脂肪酶突变体TTL-Arg59Ser/Gly60Glu/Ser61Asn/Ile62Val及其基因和应用 | |
CN110004125B (zh) | 一种海洋细菌来源新型耐碱耐有机溶剂酯酶及应用 | |
CN108841806B (zh) | 一种热稳定性提高的脂肪酶突变体 | |
CN111057691B (zh) | 一种新型gdsl家族脂类水解酶eii-3及其编码基因与应用 | |
CN111019921B (zh) | 一种高耐受性的脂类水解酶e93及其编码基因与应用 | |
Zhu et al. | Substitution of His260 residue alters the thermostability of Pseudoalteromonas carrageenovora arylsulfatase | |
CN108192906B (zh) | 一种含有低温脂肪酶基因的工程菌及其构建方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |